NCT07468279 Synchronization of Theta to Influence Memory
| NCT ID | NCT07468279 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida International University |
| Condition | Cognitive Control |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-03-13 |
| Primary Completion | 2031-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2026-03-13 with a primary completion date of 2031-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to clarify relations between brain oscillations and two cognitive functions: cognitive control and memory.
Eligibility Criteria
Inclusion Criteria: * 18 years and older * Fluent in English * Normal or corrected-to-normal vision * Willing to be photographed Exclusion Criteria: * Must not have ever had an injury to the head that's caused you to be knocked out for a period of time (e.g., from a fall, blow to the head, road traffic accident). * Must not have an uncorrected vision or physical disability that interferes with your ability to see stimuli presented briefly on a computer screen or click a mouse button rapidly. * Must not have a history of epilepsy, convulsions, or seizures (except childhood febrile seizures). * Must not have a history of fainting or syncope. * For female participants, they must not be pregnant and/or must not think they might be pregnant. * Must not have skin problems like eczema, dermatitis, or open wounds on the scalp. * Must not have had prior brain surgery. * Must not have any metal located in the head/neck (except for dental fillings). * Must not have any devices or other implants located in/near their head. This includes cochlear implants and aneurysm clips, cardiac pacemaker, or any other implanted electronic device. * Must not have a current (active) alcohol or substance use disorder, must have no recent history of withdrawal symptoms, and must be able to safely abstain from alcohol and non-prescribed/illicit drugs for at least 24 hours before the session. * Must not have any alcohol on the day of the session, must limit alcohol consumption to no more than 2 drinks (if legally permitted) in the prior 24 hours, and must not use any non-prescribed or illicit drugs in the 24 hours before the session. * Must not be sick with a fever, sleep-deprived, or feel dizzy, unwell, or intoxicated. * Must also have eaten and had fluids but not have consumed more caffeine than they typically consume. * Must not be taking anticonvulsant/anti-epileptic drugs or have ever taken them within their lifetime. * Must not be taking benzodiazepines or have taken them within the past 3 months. * Must not have had a recent change (start, stop, dose change) for any psychiatric/psychotropic medications within the past 3 months. * Must not be taking Bupropion (Wellbutrin, Zyban), Tricyclic antidepressants (e.g., amitriptyline, imipramine, clomipramine, etc.), Antipsychotics (clozapine; chlorpromazine, haloperidol, etc.), or Tramadol or have taken them within the past 3 months. * Must not have experienced cardiac problems, fibrillation, or have taken medications associated with cardiac conditions within the past 3 months. * Must not meet the diagnostic threshold for Autism Spectrum Disorder, Intellectual Disability, or Psychotic Disorders.
Frequently Asked Questions
Who can join the NCT07468279 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 59 Years, studying Cognitive Control. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07468279 currently recruiting?
Yes, NCT07468279 is actively recruiting participants. Visit ClinicalTrials.gov or contact Florida International University to inquire about joining.
Where is the NCT07468279 trial being conducted?
This trial is being conducted at Miami, United States.
Who is sponsoring the NCT07468279 clinical trial?
NCT07468279 is sponsored by Florida International University. The trial plans to enroll 90 participants.